MedPath

se of a New and Innovative Therapy for diabetes : Evaluation study

Not Applicable
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000011386
Lead Sponsor
Japan Association for Diabetes Education and Care
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10000
Inclusion Criteria

Not provided

Exclusion Criteria

1.Current use of an insulin preparation 2.Diagnosis of type 1 diabetes 3.Current treatment with an investigational drug 4.Women who are pregnant, breastfeeding, or who hope to become pregnant 5.Patients whose participation is deemed inappropriate at the discretion of the attending physician.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1 Efficacy Change in HbA1c and body weight. Differential analysis by patients characteristics or concomitant drug. 2 Safety Adverse events and those rates of occurrence
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath